Abstract P2036: Deciphering the Burden: Lead Exposure as a Major Contributor to Hypertensive Heart Disease Globally: A Global Analysis from 1990-2021

J Juveriya Yasmeen (Ascension Saint Joseph - Chicago, Chicago, Illinois, United States) N Nmair Alziadin (Tufts SOM - Portsmouth Hospital, Portsmouth, New Hampshire, United States) H Hassaan Imtiaz (Mclaren Bay Region, Saginaw, Michigan, United States) P Paritaben Bhalodia (Internal Medicine, Advocate Illinois Masonic Medical Center,, Chicago, Illinois, United States) A Anusha Parisapogu (University of Connecticut, Hartford , India) R Roopeessh Vempati (Trinity Health Oakland Hospital, Pontiac, Michigan, United States) N Naradasu Pranathi Royal (Kaplan medical prep NYC institute, New York, New York, United States) V Vinay Kumar Gadamidi (Virtua Health, Cherry Hill, New Jersey, United States) V Victor O. Adedara (St George’s University School of Medicine located in True Blue,, True Blue, Grenada) A Anjani Kumar Thota (Sinai Hospital of Baltimore, Baltimore, Maryland, United States) H Hardik Dineshbhai Desai

Abstract

Introduction: Lead exposure (LE) has been increasingly recognized as a significant risk factor for hypertensive heart disease (HHD), with no safe threshold identified for its adverse health effects. Persistent environmental contamination from sources such as old paint and industrial emissions continues to pose cardiovascular risks. Method: Using Burden of Disease Study 2021 tool, we estimated deaths and disability due to HHD attributable to LE by age, sex, year and location across the 204 countries and territories from 1990-2021. Results are shown in absolute counts and unadjusted rates (per 100,000). Results: From 1990 to 2021, the average annual percentage change (APC) in the absolute death count rose by 1.97%, disability-adjusted life years (DALYs) increased by 1.31%, and years lived with disability (YLDs) by 3%. Regionally, the highest increase in APC for deaths was observed in high-income countries at 3.54%, followed by high-SDI regions and South Asia, both at 2.95%. Regarding age, the highest number of deaths occurred in the 80-84 age group, totaling 216,409 (95% uncertainty interval: 179,011-244,186). The highest DALYs were noted in the 70-74 age group, at 3.3 million (2.8-3.7 million), and YLDs in the same age group were 178,655 (102,947-280,059). From 1990 to 2021, females saw higher total percentage changes (TPC) compared to males: deaths increased by 92% vs. 74%, DALYs by 57% vs. 43%, and YLDs by 170% vs. 134%. Conclusion: Deaths due to HHD attributable to LE accounted for 23.93% of all HHD related deaths globally in 2021. The persistent burden of HHD attributable to LE highlights a critical area for public health intervention. Reducing exposure to lead and mitigating its cardiovascular effects are imperative for global health security.

Article Details

Journal Circulation
Volume / Issue Vol. 151, Issue Suppl_1
Published March 11, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (11)

J

Juveriya Yasmeen

Ascension Saint Joseph - Chicago, Chicago, Illinois, United States

N

Nmair Alziadin

Tufts SOM - Portsmouth Hospital, Portsmouth, New Hampshire, United States

H

Hassaan Imtiaz

Mclaren Bay Region, Saginaw, Michigan, United States

P

Paritaben Bhalodia

Internal Medicine, Advocate Illinois Masonic Medical Center,, Chicago, Illinois, United States

A

Anusha Parisapogu

University of Connecticut, Hartford , India

R

Roopeessh Vempati

Trinity Health Oakland Hospital, Pontiac, Michigan, United States

N

Naradasu Pranathi Royal

Kaplan medical prep NYC institute, New York, New York, United States

V

Vinay Kumar Gadamidi

Virtua Health, Cherry Hill, New Jersey, United States

V

Victor O. Adedara

St George’s University School of Medicine located in True Blue,, True Blue, Grenada

A

Anjani Kumar Thota

Sinai Hospital of Baltimore, Baltimore, Maryland, United States

H

Hardik Dineshbhai Desai